Thomas Ogorka
Chief Executive Officer
Making a difference is important to us. In a world with more than 7,000 rare diseases for which only 200 treatments are available today there is still a lot to do. Extraordinary concerted efforts from many different stakeholders are required to accelerate the process of bringing urgently needed new medicines to the market.
Orphan Reach pioneers multi-stakeholder partnerships in the rare disease domain. We believe in a collaborative approach and the fact that we need to unite the best in class providers for the ultimate benefit of patients desperately waiting for new treatments.